Encore Rehabilitation Services LLC, which is backed by Revelstoke Capital Partners LLC, has appointed Eric A. Shuey to its board of directors. Previously, Shuey was the chief financial officer at Liberty Dialysis Holdings. Based in Farmington Hills, Michigan, Encore is a provider of rehabilitative therapy services and associated compliance and revenue cycle support services for nursing facilities, assisted living facilities, home health agencies, hospitals and schools.
FARMINGTON HILLS, Mich.–(BUSINESS WIRE)–Encore Rehabilitation Services, LLC (“Encore”), a portfolio company of Revelstoke Capital Partners LLC (“Revelstoke”), a Denver-based private equity firm, has added Eric A. Shuey to its Board of Directors.
Eric A. Shuey is an active private equity investor in the healthcare services space with more than 20 years of executive management, corporate finance and investing experience. Mr. Shuey previously served as the Chief Financial Officer of Liberty Dialysis Holdings, Inc. where he was part of the management team that grew Liberty into a leading national provider of dialysis services prior to its sale to Fresenius Medical Care AG in early 2012 for over $2.3 billion. He currently serves on the board of several leading healthcare services and IT companies including: Apixio Inc.; MedeAnalytics; National Cardiovascular Partners; Remedy Partners; and Sound Physicians, Inc. Mr. Shuey previously served as a Director at DB Capital Partners, the private equity arm of Deutsche Bank responsible for over $10 billion in assets, and a Principal at Aurora Capital Group, a $1 billion private equity firm.
Mr. Shuey earned an MBA from the Wharton School of Business, where he was a Palmer Scholar. In addition, he has completed the coursework for a Ph.D. in Management at the Wharton School and earned his BA from California State University, Fullerton with highest honors.
“Eric has broad-based healthcare services experience, both as an executive manager and investor, which will assist in strategically positioning Encore for the opportunities presented by the evolving post-acute care landscape,” said Simon Bachleda, Managing Partner at Revelstoke and Chairman of the Board of Directors at Encore.
“Encore’s recent add-on acquisitions have significantly increased our scale and expanded our services across the continuum of care. We are excited to have Eric on our Board of Directors to help Encore continue to execute on its strategy to be a leading post-acute therapy services company in the industry,” said Linda Shackelford, CEO and Co-Founder of Encore.
Encore is a provider of outcome-driven rehabilitative therapy services and associated compliance and revenue cycle support services primarily to skilled nursing facilities as well as assisted living facilities, home health agencies, hospitals and schools. Encore operates in 34 states and manages the delivery of a full spectrum of physical, occupational and speech therapy services and provides sophisticated quality, compliance and documentation capabilities to over 650 client facilities. Encore was founded in 2007 and is headquartered in Farmington Hills, Michigan.
Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies. Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build exceptional companies. Since the firm’s inception in mid-2013, Revelstoke has raised in excess of $700 million in equity commitments across its various investing entities and has completed 23 acquisitions totaling over $1.2 billion in enterprise value.